STOCK TITAN
  1. Home
  2. FPRX

Five Prime (FPRX) Stock Price, News & Analysis

FPRX NASDAQ

Company Description

Five Prime (NASDAQ: FPRX) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for FPRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
46.6M
Shares outstanding

Latest News

View All
—

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

acquisition
-0.92%

Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call

conferences earnings
+78.74%

Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash

acquisition
+78.74%

Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash

acquisition
-4.71%

Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call

conferences earnings
+5.40%

Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference

conferences

Five Prime has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, conferences, earnings, clinical trial. View all FPRX news →

SEC Filings

View All

No SEC filings available for FPRX.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

FPRX Company Profile & Sector Positioning

Five Prime (FPRX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.